Clinical trial
Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial…
NCT00168103 · CSL Behring, Industry · Completed
Key facts
| NCT number | NCT00168103 |
|---|---|
| Title | Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks |
| Official title | Human Pasteurized C1 Esterase Inhibitor Concentrate (CE1145) in Subjects With Congenital C1-INH Deficiency and Acute Abdominal or Facial HAE Attacks |
| Lead sponsor | CSL Behring, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hereditary Angioedema |
| Intervention type | Biological |
| Interventions | C1 Esterase Inhibitor, Placebo |
| Enrollment | 126 |
| Start date | Jun 1, 2005 |
| Primary completion | Oct 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 14, 2005 |
| Last update posted | Mar 31, 2015 |
| Countries | Argentina, Australia, Bulgaria, Canada, Czechia, Hungary, Israel, North Macedonia, Poland, Romania, Russia, Spain and 3 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: